key: cord-287220-mpnuhqwg
authors: Giuliani, C.; Li Volsi, P.; Brun, E.; Chiambretti, A.; Giandalia, A.; Tonutti, L.; Di Bartolo, P.; Napoli, A.
title: Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD
date: 2020-05-30
journal: Diabetes Res Clin Pract
DOI: 10.1016/j.diabres.2020.108239
sha: 
doc_id: 287220
cord_uid: mpnuhqwg

Abstract SARS-Cov2 infection has recently spread to Italy with important consequences on pregnancy management, mother and child health and mother-child contact. Breastfeeding improves the health of mother and child and reduces risk of neonatal infection with other pathogens that are likely to cause serious illness. To date no evidence confirmed COVID-19 vertical transmission from infected pregnant mother to their fetus. However it is well known that an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact. Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding. Woman Study Group of AMD, after reviewing current knowledge about COVID-19 vertical transmission and the compatibility of breastfeeding in COVID-19 mother, the available recommendations from Health Care Organizations and main experts opinions, issued the following suggestions on breastfeeding during the COVID-19 pandemic, addressed both to mothers with and without diabetes It should be considered that following suggestions may change in the future when more evidence is acquired regarding SARS-Cov2 infection.

Breastfeeding improves the health of mother and child with benefits for families and positive social and economic impact 1 . Currently there is no robust evidence for intrauterine vertical transmission of COVID-19 from infected pregnant mothers to their fetuses 2 . A Chinese case report 3 described the first case of neonatal COVID-19 infection in China whose mother was confirmed with COVID-19. However, whether the case is a vertical transmission from mother to child cannot be confirmed due to the late execution of the neonatal oropharyngeal swab, performed 36 hours after birth. A retrospective analysis of 9 cases of women with COVID-19 pneumonia confirmed diagnosis subjected to cesarean section in China found no vertical transmission of infection from mother to infant. Virus research on amniotic fluid, umbilical cord blood and nasopharyngeal swab of newborns has always been negative 4 .

Chen Y et al 5 reported four cases of live born infants, born to pregnant women with the COVID-19 infection in Wuhan: newborns had no clinical signs of disease and were tested negative for the virus at delivery. Two articles from two Chinese research teams present details of 3 neonates who may have been infected with severe acute respiratory syndrome SARS-Cov2 in utero from mothers with 'COVID-19' 6, 7 . Evidence for such transmission was based on high IgM antibody levels in neonatal blood after birth. All infants also had high IgG antibody values and high cytokine levels, though IgG antibody may have crossed the placenta from the mother to the fetus. None of the three neonates had a positive reverse transcriptasepolymerase chain reaction test result supporting utero transmission 8 However, the suggestion of in utero transmission rests on IgM detection in the three neonates; IgM antibodies are too large to cross the placenta, therefore their detection in a newborn could be assumed to reflect fetal production following in utero infection even though IgM assays can be prone to false positive and false negative-results. On the other hand, although a study on three Covid-19 mothers suggests that there are no morphological changes related to infection in the three placentas, it is not well known whether a hypothetical alteration of placental architecture could favor macromolecules passage from infected mother to infant 9 . Despite the kinetics of IgM production and decay in SARS-Cov-2 infections are not yet known, the rapid IgM decline reported in this patients was very rapid raising the possibility that the laboratory findings are not evidence of true congenital infection, rather could represent artifact. Finally, the variability in sensitivity and specificity of IgM assay among laboratories, suggests caution in interpreting these results.

In conclusion, despite SARS-CoV-2 in utero transmission could be possible as virus nucleic acid has been detected in blood sample 10 and other vertical virus transmission from mother to infant is well documented, more definitive evidence is needed before the provocative available findings can be used to counsel pregnant women that their fetuses are at risk from congenital infection with SARS-Cov-2. 8 On the other hand, it is well known that, after birth, an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact. 8, 11 Based on the available limited literature, neonatal COVID-19 appears to have a horizontal transmission and to be paucisymptomatic or asymptomatic compared to older age groups. Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding and comply with the recommended hygiene measures to avoid the risk of transmission through breath droplets 12 . At the New York-Presbyterian Allen Hospital and Columbia University Irving Medical Center 215 obstetrical patients, presenting for delivery between march 22 and april 4 2020, were screened for Covid-19 symptoms and tested for SARS-Cov2. 1.9% of women were found to be positive and symptomatic and 13.5% to be positive and asymptomatic. Therefore the authors conclude that the potential benefits of a universal testing approach include the ability to use Covid-19 status to determine hospital isolation practices to protect mothers, babies, and health care teams during these challenging times. 13 In limited studies on women with COVID-19 and another coronavirus infection, Severe Acute Respiratory Syndrome (SARS-CoV), the virus has not been detected in breast milk; nonetheless, we do not know whether mothers with COVID-19 can transmit the virus via breast milk. 14 Moreover, some experts speculate that, similar to the 2002-2003 SARS-Co-V epidemic 15 , specific SARS-CoV-2 antibodies pass via the breast milk from the COVID-19 mother to the infant within a few days after the onset of the disease, possibly moderating the clinical expression of infant's infection 16 .

Due to scarce evidence, the available recommendations are just 'expert opinion' Chinese Pediatrics COVID-19 working group recommends maternal separation precluding breastfeeding because COVID-19 can cause severe illness. They suggest infant feeding with formula or possibly donor breast milk 17 . Marinelli 18 describes the effects of the pandemic on the management of donated human milk. In China, both donation and demand for human milk have decreased as a result of the pandemic; In Italy donations have decreased, probably because women prefer not to go to the hospital. The lack of donated human milk makes the need for breast-feeding even more evident whenever possible.

However, as breastfeeding reduces risk of infection with other pathogens that are likely to cause serious illness, the main scientific and public institutions (WHO, UNICEF, ISS, IUOG, RCOG and ABM) 19, 20, 21, 22, 23, 24 safeguard maternal breastfeeding and question the Chinese recommendation to routinely separate the newborn from the COVID-19 mother.

Centers for Disease Control and Prevention (CDC) 25 state that "the determination of whether or not to separate a mother with known or suspected COVID-19 and her infant should be made on a case-by-case basis using shared decision-making between the mother and the clinical team" and considering many factors (the clinical condition of the mother and of the infant, SARS-CoV-2 testing results of mother and infant (a positive infant test would negate the need to separate), desire to feed at the breast, facility capacity to accommodate separation or colocation, the ability to maintain separation upon discharge, other risks and benefits of temporary separation of a mother with known or suspected COVID-19 and her infant)

have delivered accurate provisional indications on the management of mother and neonate 16 , coherent with WHO, UNICEF, ISS, IUOG, RCOG and ABM recommendations, summarized in TABLE 1.

We recommend these suggestions to be considered valid both for women with and without diabetes According to WHO, UNICEF, ISS, IUOG, RCOG, CDC, ABM and FIGO 26 and in particular with SIN, UENPS and Italian Health Ministry. 27 Whenever possible, the preferred option is that of joint management of mother and newborn, in order to facilitate the interaction and initiation of breastfeeding.

However the decision about whether or not to separate mother and neonate must be individualized, taking into account the parents information-consent, good health status of both the mother and her neonate and capacity to care for her neonate, the results of RT-PCR-RNA test for COVID-19, the context and the local epidemiological situation of current COVID-19 pandemic. It's critical all doctors caring the family discuss in detail about the risks and benefits of breastfeeding with parents in order to individualize any feeding choice. 23 All women admitted to the hospital for delivery should be tested for SARS-Cov2 taking into account the context and the local epidemiological situation. 13 In case of a paucisymptomatic suspected COVID-19 mother feeling able to manage the newborn independently, mother and newborn can be managed together and breastfeeding can be started or maintained, pending mother test response (performed according to the Real Time PCR protocols for SARS-CoV-2 indicated by WHO).

If mother's test is positive, rooming-in and breastfeeding is applicable, paying attention to normal precautions of airborne respiratory diseases. COVID-19 mothers who are breastfeeding or practising skin-to-skin contact or kangaroo mother care should practise respiratory hygiene to avoid transmitting the virus to her baby:

 The room should be isolated, not allowing visits of relatives and friends.  The baby should be ensured a two meters safe distance  The mother should wear a surgical face mask during breastfeeds and intimate contact with the newborn.  The mother should perform hand hygiene before and after contact with the child  Routinely clean and disinfect surfaces which the symptomatic mother has been in contact with.  There is no need for the mother to use FFP2 or FFP3.

If expressing breast milk with a manual or electric breast pump, the mother should wash her hands before touching any pump or bottle parts and follow recommendations for proper pump cleaning after each use.

If possible, consider having someone who is well to care for and feed the expressed breast milk to the infant.

If mother has evident respiratory infection symptoms (fever, cough and respiratory secretions, myalgias, sore throat, asthenia, dyspnoea), mother and infant should be transiently separated, pending test response:

 in case of positive test, mother and infant continue to be managed separately;  in case of negative test, rooming-in for mother and newborn is applicable with normal precautions for airborne respiratory diseases. Once mother's clinical condition has improved, the newborn can be breastfed directly. In case of separation of mother and neonate, the expression, transportation and administration of the fresh mother's milk to newborn is recommended. Expressed breast milk should not be pasteurized, as it is not believed to be a vehicle of infection. Moreover, pasteurization reduces the biological and immunological value of human milk. In cases of serious maternal infection, breast milk expression may not to be carried and donated human milk should be considered.

The compatibility of breastfeeding with drugs eventually administered to a mother with COVID-19 should be assessed on a case-by-case basis.

Hospital discharge of a paucisymptomatic COVID-19 mother together with a healthy SARS-CoV-2 negative neonate should be done appropriately.

Going home as early as 48 hours after childbirth might be an option only in cases of hospital overload. In most cases, one week hospital stay for surveillance of the newborn and repetition of the pharyngeal swab for SARS-CoV-2 at discharge is preferable.

Neonatal COVID-19 follow-up can be stopped on the 28th day after discharge, if the pharyngeal swab for SARS-CoV-2 is confirmed negative.

Breastfeeding confers health benefits to women with a history of GDM in terms of glucose tolerance in the early and late postpartum period. [28] [29] Women with diabetes have to intensify their glycemic control during COVID infection as well as during any other infectious disease that could be responsible for metabolic imbalance. 30 During puerperium more attention is to be paid to the balance of fluids that can be influenced both by postpartum fluid retention and blood sugar levels. Patients with severe Covid-19 disease are subjected to administration of cortisone with possible subsequent glycemic imbalance even in women with prior gestational diabetes. 31 A light meal before suckling is recommended in women on insulin treatment to prevent post meal hypoglycemia (90-180 minutes after suckling). 32 Breastfeeding leads to a decreased need in total daily basal insulin caused by increased glucose use during lactation, thus insulin dose should be carefully evaluated in breastfeeding women. 33 NO; use of expressed milk.** Pasteurization not recommended YES *In addition, adequate protection measures on the part of health care personnel, according to the indication of the Ministry of Health of Italy. **Mother's fresh milk should be expressed with a dedicated manual or electrical breast pump. The mother should always wash her hands before and after touching bottles and all breast pump parts, following recommendations for proper washing of the breast pump after each use. ***Room divider or curtain, surgical face mask for the mother during breastfeeds and intimate contact with the newborn, careful washing of hands, placing the baby's cradle at a distance of 2 meters from the mother's head, no visits of relatives and friends. No need of the mother to use FFP2 or FFP3 face mask (Radonovich, Simberkoff & Perl 2019; UENPS 2020).

Position Statement on Breastfeeding from the Italian Pediatric Societies

Intrauterine vertical transmission of SARS-CoV-2: what we know so far

A case report of neonatal COVID-19 infection in China

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Infants Born to Mothers With a New Coronavirus (COVID-19). Front Pediatr

Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn

Antibodies in infants born to mothers with COVID-19 pneumonia

Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed

Pregnant women with new coronavirus infection: a clinical characteristics and placentalpathological analysis of three cases. Zhonghua Bing Li Xue Za Zhi

Detection of SARS-CoV-2 in different types of clinical specimens

Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery

Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review

SARS and pregnancy: a case report

Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies

Working Committee on Perinatal and Neonatal Management for the Prevention and Control of the 2019 Novel Coronavirus Infection. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First Edition)

International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic

Clinical management of severe acute respiratory infections (SARI) when COVID-19 disease is suspected. Interim Guidance

THE CONTEXT OF COVID-19

Nuovo Coronavirus consigli dell'Istituto superiore di sanità per le donne in gravidanza o durante l'allattamento

ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals

Royal College of Midwives, Royal College of Paediatrics and Child Health, Public Health England and Health Protection Scotland. Coronavirus (COVID-19) Infection in Pregnancy. Information for healthcare professionals

Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals

Direzione Generale della Programmazione Sanitaria & Direzione Generale per l'Igiene e la Sicurezza degli ambienti e la Nutrizione. COVID-19: indicazioni per gravida-partoriente, puerpera

Long Lasting Effects of Breastfeeding on Metabolism in Women with Prior Gestational Diabetes

Lactation Duration and Progression to Diabetes in Women Across the Childbearing YearsThe 30-Year CARDIA Study

Continuous glucose monitoring during breastfeeding in women with recent gestational diabetes mellitus

Joint British Diabetes Societies (JBDS) for Inpatient Care. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group

Breastfeeding and the basal insulin requirement in type 1 diabetic women

Glycaemic behaviour during breastfeeding in women with Type 1 diabetes. Diabetic medicine

We thank all the participants for their contributions to this study.

All authors contributed equally. All authors have approved the final manuscript.

The authors have no conflict of interest to declare.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors.